Nearly one in five pediatric hospital deaths in the United States involve sepsis, according to a new national study published ...
NeurAxis, Inc. (AMEX:NRXS) Q4 2025 Earnings Call Transcript March 19, 2026 Operator: Ladies and gentlemen, thank you for standing by. Welcome to the NeurAxis, Inc. fourth quarter 2025 financial ...
Revenues increased 27% year over year to $968 thousand in 4Q25. Operating loss increased 17% year over year, primarily due to higher selling expenses directly related to increased sales volume and ...
A 230-basis-point gross margin decline in 2025 was attributed to higher discounting in financial assistance programs and ...
NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic ...
Abeona Therapeutics Inc (ABEO) reports growing patient demand and significant financial gains, despite facing operational ...
Good morning, everyone, and welcome to the Abeona Therapeutics Full Year 2025 Results Conference Call. [Operator Instructions] Please note this conference is being recor ...
Abeona Therapeutics Inc. (NASDAQ:ABEO) Q4 2025 Earnings Call Transcript March 17, 2026 Abeona Therapeutics Inc. beats ...
Q4 2025 Earnings Call March 18, 2026 4:30 PM EDTCompany ParticipantsMaria Sainz - CEO, President & DirectorBrett Hale - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results